DOI 10.1126/science.273.5277.974 The paper that first described Ipamorelin, and made the case that it was unusually selective
You deserve clarity, a plan, and a team that takes your concerns seriously
But in this episode, were actually going to look at what seems to be a favorite topic in pharmacy right now GLP-1 agonists that we use for diabetes and weight loss
Pharmacology 96(56):217225 Aimo A, Castiglione V, Borrelli C, Saccaro LF, Franzini M, Masi S, Emdin M, Giannoni A (2020) Oxidative stress and inflammation in the evolution of heart failure: from pathophysiology to therapeutic strategies
Front Neurosci 15: 774050
Another previous study (Mantsiou et al., 2020) performed that no significant differences on the body weight loss was observed in combination therapy compared with SGLT-2i monotherapy when using the long-term data